Zobrazeno 1 - 10
of 311
pro vyhledávání: '"BRUNO GUERCI"'
Autor:
George Riley, Nicolas Scheyer, Marc Klein, Isabelle Merlot, Bruno Guerci, Elodie Jeanbert, Lea Demarquet
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
ObjectiveThe primary aim of this study was to identify predictive factors associated with onset of de-novo clinically significant pituitary insufficiencies following endoscopic endonasal surgery (EES) for pituitary adenomas. The secondary objective e
Externí odkaz:
https://doaj.org/article/58ce5be86b2b4d5f949a90a60d9771b0
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes mellitus (T2DM). In this review
Externí odkaz:
https://doaj.org/article/6420101921534b9f9d011a67767b1819
Autor:
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D. Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino, Bruno Guerci, Hiddo J. L. Heerspink, Baruch Itzhak, Linong Ji, Mikhail Kosiborod, Nebojša Lalić, Michael Lehrke, Nikolaus Marx, Michael Nauck, Helena W. Rodbard, Giuseppe M. C. Rosano, Peter Rossing, Lars Rydén, Francesca Santilli, Petra-Maria Schumm-Draeger, Per Olav Vandvik, Tina Vilsbøll, Christoph Wanner, Carol Wysham, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-16 (2022)
Abstract The 7th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Renal, and Glycemic Outcomes, was held virtually on November 18–19, 2021. Pursuing the tradition of the previous summits, this reference congress served as a platform fo
Externí odkaz:
https://doaj.org/article/00e116eff4ae44ebb18f8fbed0bc075e
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract The recent results of Cardiovascular Outcomes Trials (CVOTs) in type 2 diabetes have clearly established the cardiovascular (CV) safety or even the benefit of two therapeutic classes, Glucagon-Like Peptide-1 receptor agonists (GLP-1 RA) and
Externí odkaz:
https://doaj.org/article/c5cb3e8640224a6aa7275a1243794ca7
Autor:
Denis Raccah, Bruno Guerci, Mayank Ajmera, Keith Davis, Juliana Meyers, Elisheva Lew, Alka Shaunik, Lawrence Blonde
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 2, Iss 3, Pp n/a-n/a (2019)
Summary Aims To assess the effect of duration of hyperglycaemia before basal insulin (BI) initiation on clinical outcomes in type 2 diabetes (T2D). Materials and methods Patients with T2D who initiated BI during 2009‐2013, had continuous enrolment
Externí odkaz:
https://doaj.org/article/aa5a8182fe404f4b976da530ff15d82c
Autor:
Pierre-Yves Benhamou, ProfMD, Sylvia Franc, MD, Yves Reznik, ProfMD, Charles Thivolet, ProfMD, Pauline Schaepelynck, MD, Eric Renard, ProfMD, Bruno Guerci, ProfMD, Lucy Chaillous, MD, Celine Lukas-Croisier, MD, Nathalie Jeandidier, ProfMD, Helene Hanaire, ProfMD, Sophie Borot, MD, Maeva Doron, Pierre Jallon, Ilham Xhaard, PhD, Vincent Melki, MD, Laurent Meyer, MD, Brigitte Delemer, ProfMD, Marie Guillouche, MD, Laurene Schoumacker-Ley, MD, Anne Farret, MD, Denis Raccah, ProfMD, Sandrine Lablanche, MD, Michael Joubert, ProfMD, Alfred Penfornis, ProfMD, Guillaume Charpentier, MD
Publikováno v:
The Lancet: Digital Health, Vol 1, Iss 1, Pp e17-e25 (2019)
Summary: Background: Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system impro
Externí odkaz:
https://doaj.org/article/bf42d9c4d29145c98bb3dcf6ec9f667f
Autor:
Bruno Vergès, Bruno Guerci, Vincent Durlach, Catherine Galland-Jos, Jean Louis Paul, Laurent Lagrost, Philippe Gambert
Publikováno v:
Journal of Lipid Research, Vol 42, Iss 12, Pp 2021-2029 (2001)
Plasma apolipoprotein A-IV (apoA-IV) levels are found elevated in hypertriglyceridemic patients. However, the relationship between plasma apoA-IV level and postprandial lipemia is not well known and remains to be elucidated. Thus, our objective was t
Externí odkaz:
https://doaj.org/article/cd05732b9b1642a18a11e85229c75ad0
Autor:
Bruno Guerci, Yves Reznik, Pauline Schaepelynck, Emmanuel Sonnet, Salha Fendri, Marie-Françoise Jannot-Lamotte, Bogdan Nicolescu-Catargi, Valéria Cosma, Nathalie Texier, Justine Lahaye, Emmanuel Capitaine, Jean-Pierre Riveline
Publikováno v:
Médecine des Maladies Métaboliques. 17:281-290
Autor:
Charlotte Costentin, Cyrielle Caussy, Dominique Valla, Pierre Gourdy, Lawrence Serfaty, Jean-Michel Petit, Vincent Leroy, Aldo Trylesinski, Bruno Guerci
Publikováno v:
Médecine des Maladies Métaboliques. 17:271-280
Autor:
Camille Gosseaume, Thierry Fournier, Isabelle Jéru, Marie-Léone Vignaud, Isabelle Missotte, Françoise Archambeaud, Xavier Debussche, Céline Droumaguet, Bruno Fève, Sophie Grillot, Bruno Guerci, Sylvie Hieronimus, Yves Horsmans, Estelle Nobécourt, Catherine Pienkowski, Christine Poitou, Jean-Paul Thissen, Olivier Lascols, Séverine Degrelle, Vassilis Tsatsaris, Corinne Vigouroux, Camille Vatier
Publikováno v:
European Journal of Endocrinology. 188:273-281
ObjectiveThe adipogenic PPARG-encoded PPARγ nuclear receptor also displays essential placental functions. We evaluated the metabolic, reproductive, and perinatal features of patients with PPARG-related lipodystrophy.MethodsCurrent and retrospective